• In early August 2026, Northrop Grumman Corporation announced two multi-year framework agreements worth over US$3.00 billion to accelerate production of key components for the Patriot Advanced Capability-3 Missile Segment Enhancement and Terminal High Altitude Area Defense systems, working with the U.S. Department of War and Lockheed Martin to reinforce integrated air and missile defense.
• An important takeaway is Northrop Grumman’s significant investment in expanding solid rocket motor capacity and long-standing missile component expertise, which underpins its role as a core supplier to U.S. and allied defense programs.
• We’ll now examine how these long-term, multi-billion-dollar missile-defense agreements may influence Northrop Grumman’s investment narrative and future program visibility.

AI is about to change healthcare. These 42 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10b in market cap - there's still time to get in early.

Northrop Grumman Investment Narrative Recap

To own Northrop Grumman, you need to believe in sustained demand for advanced U.S. and allied defense systems and the company’s ability to execute on large, complex programs. The new US$3.0 billion-plus PAC-3 MSE and THAAD framework agreements appear to support the short term catalyst of higher visibility in missile defense, while leaving the key risk of heavy reliance on major government programs like B-21 and Sentinel firmly in focus.

Among recent announcements, the July 2026 decision to raise full year sales guidance to US$43.75–US$44.25 billion feels most relevant here, as it reflects how growing munitions and missile defense work is already flowing into Northrop’s top line expectations. These missile component agreements fit into the same story of capacity expansion and program ramp ups, but investors still need to weigh that against the execution and cost overrun risks tied to such intensive capital spending.

Yet behind the large missile defense awards, investors still need to think carefully about the concentration risk in a few massive U.S. programs and what happens if...

Northrop Grumman's narrative projects $50.8 billion revenue and $4.7 billion earnings by 2029.

Uncover how Northrop Grumman's forecasts yield a $643.62 fair value, a 13% upside to its current price.

Exploring Other Perspectives

Two Simply Wall St Community valuations cluster between US$643.62 and US$684.77 per share, showing how differently private investors can view Northrop Grumman. Set against the heavy dependence on large U.S. government programs, this spread of views is a useful reminder to compare multiple scenarios for the company’s future performance.

Explore 2 other fair value estimates on Northrop Grumman - why the stock might be worth just $643.62!

The Verdict Is Yours

Don't just follow the ticker - dig into the data and build a conviction that's truly your own.

• A great starting point for your Northrop Grumman research is our analysis highlighting 3 key rewards and 1 important warning sign that could impact your investment decision.
• Our free Northrop Grumman research report provides a comprehensive fundamental analysis summarized in a single visual - the Snowflake - making it easy to evaluate Northrop Grumman's overall financial health at a glance.

Ready To Venture Into Other Investment Styles?

Don't miss your shot at the next 10-bagger. Our latest stock picks just dropped:

• Capitalize on the AI infrastructure supercycle with our selection of the 56 best 'picks and shovels' of the AI gold rush converting record-breaking demand into massive cash flow.
• The future of work is here. Discover the 36 top robotics and automation stocks leading the charge in AI-driven automation and industrial transformation.
• Find 51 companies with promising cash flow potential yet trading below their fair value.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.